Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis

加州大学戴维斯分校临床肿瘤学 (K12) Paul Calabresi 职业发展奖

• 批准号: 10018465
• 负责人: PRIMO N. LARA
• 金额: $ 79.67万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-01-01 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10018465
• 关键词: Automobile Driving; Basic Science; Cancer Patient; Center for Translational Science Activities; Clinical; Clinical Oncology; Clinical Oncology Supplement (K12); Clinical Research; Clinical Skills; Clinical Trials; Communication; Competence; Comprehensive Cancer Center; Custom; Development; Devices; Ensure; Environment; Ethics; Evaluation; Faculty; FarGo; Funding; Goals; Grant; Infrastructure; Investigation; K-Series Research Career Programs; Language; Malignant Neoplasms; Mentors; Mentorship; New Agents; Oncology; Patients; Program Development; Research; Research Design; Research Personnel; Research Project Grants; Research Training; SECTM1 gene; Science; Scientist; Time; Training; Translational Research; Vision; Writing; base; cancer clinical trial; career; career development; clinical investigation; didactic education; drug development; drug discovery; evidence base; improved outcome; innovation; interest; medical schools; multidisciplinary; patient oriented; patient oriented research; programs; research and development; skills; success; translational scientist

 DESCRIPTION (provided by applicant): The overarching goal of the UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program (CDP; PI, Primo Lara, Jr. MD) is to nurture clinician or basic-translational junior faculty to become independent, patient-oriented cancer researchers who are highly trained in translational, team-driven research. Using 1) core competencies, 2) advanced oncology coursework, 3) career development, 4) mentored research, and 5) cross-cultural exposure, the CDP provides two new scholars per year (six at any one time) with training aimed at honing ideas and skills that go far beyond their initial disciplinary boundaries. Scholars will overcome language and cultural barriers that typically exist between clinical and basic-translational researchers, take advantage of the collaborative research environment at UC Davis, participate in multidisciplinary and translational forums, and gather essential skills in research design, clinical trial development, team science, grant writing ethical conduct of research, communication, and career development. The vision is to enhance translational research by training clinician researchers to incorporate and utilize basic/correlatie science in their pursuit of clinical trials ("Clinical Track"), and conversely, driving basic scienists towards patient-driven drug development and clinical research ("Basic/Translational Track"). To maintain the emphasis on patient- driven clinical research, all CDP scholars, under the mentorship of both a clinical mentor and basic/translational mentor, will be required to develop and initiate/conduct their own investigator-initiated clinical trial during the training period. Th program will leverage the outstanding research, training, and evaluation expertise and infrastructure of the NCI-designated UC Davis Comprehensive Cancer Center, NCATS-funded Clinical and Translational Research Center (CTSC), and School of Medicine Career Development Program. It will be overseen and enhanced by a highly organized internal Oversight Committee and external Advisory Board. Overall, the CDP seeks to accomplish the following specific aims: 1) Offer a competency-based didactic curriculum to promote team science, encourage translational research, and hone essential skills for clinical trial development and career/research success; 2) Oversee individualized patient- oriented research projects customized to the interests and needs of each scholar; and 3) Provide oversight of scholar training to ensure the progressive development of a cadre of fully competent interdisciplinary-oriented researchers who can successfully conduct translational cancer clinical trials with investigational new agents or devices. These specific aims will enable the building of a critical mass of trained researchers at UC Davis at the forefront of innovative, impactful, evidence-based research, who can oversee research that encompasses the entire continuum of research from basic science (target identification and drug discovery) through translational science (drug development and correlative science) to clinical investigation. By doing so, we offer the potential of both enhancing the success of clinician scientists and improving outcomes for cancer patients.